<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2016-05742_2-660-12182</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="SV">Prevention av perinatal mortalitet. Ett storskaligt implementeringsprojekt med facilitering av grupper i olika h&#xE4;lso- och sjukv&#xE5;rdssytem</narrative>
   <narrative xml:lang="EN">Scaling up prevention of perinatal deaths. Implementation research on evidence-based participatory interventions  across diverse health systems</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The time before and after birth, the perinatal period, is the time of an annual 300,000 maternal deaths, 3 million stillbirths and 3 million newborn deaths. There is robust evidence that use of facilitated participatory groups is an effective social innovation to prevent a large proportion of these deaths to happen. No large scale-up of this promising innovation has so far taken place. The aim of this project is to adapt, implement, evaluate and communicate a contextually appropriate social innovation, the PeriScope model, for perinatal health in Vietnam and Nepal representing low - high maternal and neonatal mortality. The project targets primary and secondary health system levels and engage stakeholder groups with more than 5,400 key members, health care staff and managers to identify and act on local challenges, quality of care issues and health system obstacles. The project will be based on problem-solving cycles and study its effect on 388,000 births, to our knowledge the largest implementation study in this field. The PeriScope will make health systems more responsive and sustainable, reduce barriers currently preventing the uptake of safe, efficient and equitable perinatal health services. This project will allow for researcher with complimentary skills to embark on previous achievements and develop a strong collaboration. Lessons from this scale-up can be transferred to other settings, enabled by the active participation of the WHO, the UNICEF, and the World Bank.</narrative>
   <narrative xml:lang="SV">Tiden kring f&#xF6;delsen, den perinatala perioden, &#xE4;r den tid i livet som &#xE5;rligen omfattar 300,000 m&#xF6;drad&#xF6;dsfall, 3 miljoner d&#xF6;df&#xF6;dda barn och 3 miljoner nyf&#xF6;dda, som d&#xF6;r under den f&#xF6;rsta levnadsm&#xE5;naden. Det finns idag en gedigen kunskap om att s&#xE5; kallade faciliterade grupper, som arbetar tillsammans &#xE4;r en effektiv social innovation f&#xF6;r att framg&#xE5;ngsrikt identifiera och agera mot lokala problem f&#xF6;r f&#xF6;rb&#xE4;ttrad perinatal h&#xE4;lsa och &#xF6;verlevnad. Trots att metoden f&#xF6;respr&#xE5;kas av WHO har ingen storskalig implementering pr&#xF6;vats. Det finns &#xE4;ven ingen praktisk v&#xE4;gledning om hur innovationen ska implementeras eller vilka effekter som kan f&#xF6;rv&#xE4;ntas. I det f&#xF6;reslagna projektet avser vi att implementera och utv&#xE4;rdera denna metod i stor skala i Nepal och Vietnam. H&#xE4;lsoutfall, kostnad och process kommer att dokumenteras och utv&#xE4;rderas, och riktlinjer och material kommer att produceras f&#xF6;r att anv&#xE4;nda metoden &#xE4;ven i andra l&#xE4;nder. Projektet &#xE4;r inriktat mot s&#xE5;v&#xE4;l prim&#xE4;rv&#xE5;rdsniv&#xE5;, sjukhus och administrat&#xF6;rer med ansvar f&#xF6;r h&#xE4;lso- och sjukv&#xE5;rdsfr&#xE5;gor och planering i de ing&#xE5;ende studieomr&#xE5;dena. Total kommer projektet att engagera 5400 nyckelpersoner och m&#xE4;ta effekter p&#xE5; 388,000 f&#xF6;rlossningar. Innovationen antas bidra till att skapa b&#xE4;ttre fungerande h&#xE4;lsosystem p&#xE5; lokal- och distriktsniv&#xE5;, och ge redskap f&#xF6;r att aktivt och systematiskt arbeta f&#xF6;r f&#xF6;rb&#xE4;ttring av v&#xE5;rden av m&#xF6;drar och nyf&#xF6;dda barn. Projektet inkluderar mycket v&#xE4;l meriterade forskare med kompletterande kunskaper fr&#xE5;n olika forskningsf&#xE4;lt och l&#xE4;ros&#xE4;ten i Sverige, England, Nepal och Vietnam. I projektets referensgrupp medverkar framst&#xE5;ende representanter f&#xF6;r WHO, UNICEF och V&#xE4;rldsbanken.</narrative>
  </description>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Uppsala universitet</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2017-01-01" type="1"></activity-date>
  <activity-date iso-date="2017-01-01" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="NP" percentage="100">
   <narrative xml:lang="EN">Nepal</narrative>
  </recipient-country>
  <sector code="121" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Health, General</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Medical research</narrative>
  </sector>
  <tag code="3.B" vocabulary="3">
   <narrative xml:lang="SV">3.b - St&#xF6;dja forskning om och utveckling av vaccin och l&#xE4;kemedel mot de smittsamma och icke-smittsamma sjukdomar som i f&#xF6;rsta hand drabbar utvecklingsl&#xE4;nder. S&#xF6;rja f&#xF6;r tillg&#xE5;ng till ekonomiskt &#xF6;verkomliga grundl&#xE4;ggande l&#xE4;kemedel och vaccin, i enlighet med Doha-deklarationen om TRIPS-avtalet och folkh&#xE4;lsa, i vilken det bekr&#xE4;ftas att utvecklingsl&#xE4;nderna har r&#xE4;tt att fullt ut utnyttja den flexibilitet som avtalet om handelsrelaterade aspekter av immaterialr&#xE4;tter erbjuder f&#xF6;r att skydda folkh&#xE4;lsan och, framf&#xF6;r</narrative>
   <narrative xml:lang="EN">3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public healt</narrative>
  </tag>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2017-01-01"></period-start>
   <period-end iso-date="2017-12-28"></period-end>
   <value currency="USD" value-date="2017-01-01">16965.016965017</value>
  </budget>
  <budget>
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-28"></period-end>
   <value currency="USD" value-date="2018-01-01">16685.0777869833</value>
  </budget>
  <budget>
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-28"></period-end>
   <value currency="USD" value-date="2019-01-01">15334.3415222242</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-10-24"></transaction-date>
   <value currency="USD" value-date="2016-10-24">50838.5437971133</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-28"></transaction-date>
   <value currency="USD" value-date="2017-01-28">16965.016965017</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-01-28"></transaction-date>
   <value currency="USD" value-date="2018-01-28">16685.0777869833</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-01-28"></transaction-date>
   <value currency="USD" value-date="2019-01-28">15334.3415222242</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
